Dr Jacqueline Tearle

Jacqueline completed her Ph.D. at EMBL Australia node in Single Molecule Science, UNSW, under the supervision of A/Prof. Maté Biro, where she used live-cell microscopy and single-cell transcriptomics to investigate cancer cell escape and invasion. She joined Garvan in 2022 as a Postdoctoral Researcher in the Gut Immunogenomics group, led by Dr. Kylie James. Jac’s current research involves using genomic and transcriptiomic approaches to characterise cellular and microbial drivers of intestinal disease such as early-onset colorectal cancer. Jac is particularly interested in understanding the impact of modern lifestyle factors on gut health, and is passionate about using this information to develop more relevant therapies, reduce preventable gut pathologies, and support the societal change needed to protect future generations.